Dr. Olivier Clément, PhD, and Dr. Pierre-Henri Lefevre[email protected]Clinical NewsGadolinium chelates for MRI: Where are we now?The safety of MRI contrast agents came under close scrutiny at the Journées Francophones de Radiologie congress. Dr. Olivier Clément, PhD, from Paris and Dr. Pierre-Henri Lefevre from Nîmes provided timely summaries of the current and future status of these products and asked what the literature tells us.October 17, 2016Page 1 of 1Top StoriesMRIMulti-organ MRI shows no added benefit in major UK Long COVID trialA major UK trial found no benefit from routinely adding multi-organ MRI to specialist Long COVID care. Abnormalities were detected, but fatigue and quality of life did not improve.CTEurope’s lung screening training gaps sharpen focus on implementationRadiology EducationEBR accepts registrations for EDiR, launches EDiR AcademyHomeFDG-PET/CT sharpens surveillance after colorectal liver metastasis treatmentMolecular ImagingScottish team designs 10-year sustainability model for preclinical imaging
